1 |
(2)-epigallocatechin-3-gallate (egcg) |
Epigallocatechin |
- |
- |
- |
008 [1] 8 💬 |
2 |
Capsules with 160 mg teavigo (at least 94% egcg) |
Epigallocatechin gallate |
- |
- |
- |
013 [1] 13 💬 |
3 |
Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus egcg |
Amiodarone |
[2] D00636 D00636, D02910 D02910 💬 |
ADRA1A [16] ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [31] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
028 [1] 28 💬 |
4 |
Egcg |
Epigallocatechin gallate |
- |
- |
- |
006 [9] 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
5 |
Egcg + tocotrienol |
Epigallocatechin gallate |
- |
- |
- |
299 [1] 299 💬 |
6 |
Egcg as putative neuroprotective agent |
Epigallocatechin gallate |
- |
- |
- |
017 [1] 17 💬 |
7 |
Egcg fontup |
Epigallocatechin gallate |
- |
- |
- |
206 [1] 206 💬 |
8 |
Epigallocatechin-3-gallate (egcg) |
Epigallocatechin |
- |
- |
- |
028 [2] 28, 85 💬 |
9 |
Green tea polyphenols (egcg/ecg) |
Epigallocatechin gallate |
[1] D06903 D06903 💬 |
- |
- |
006 [1] 6 💬 |
10 |
Sunphenon egcg |
Epigallocatechin gallate |
- |
- |
- |
013 [3] 13, 17, 113 💬 |
11 |
Sunphenon egcg tm |
- |
- |
- |
- |
013 [1] 13 💬 |